Structures of CD200/CD200 receptor family and implications for topology, regulation, and evolution

Structure

Volumn 21, Issue 5, 2013, Pages 820-832

  Hatherley, Deborah ^a   Lea, Susan M ^a   Johnson, Steven ^a   Barclay, A Neil ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; CD200 RECEPTOR; RECOMBINANT PROTEIN;

ARTICLE; BONE MARROW CELL; HOMEOSTASIS; HUMAN; LIGAND BINDING; MEMBRANE STRUCTURE; MOLECULAR EVOLUTION; MOUSE; MUTAGENESIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN STRUCTURE; REGULATORY MECHANISM; SEQUENCE ANALYSIS; X RAY CRYSTALLOGRAPHY;

AMINO ACID SEQUENCE; ANTIGENS, CD; ANTIGENS, SURFACE; BIOLOGICAL EVOLUTION; CRYSTALLOGRAPHY, X-RAY; MEMBRANE GLYCOPROTEINS; MYELOID CELLS; SURFACE PLASMON RESONANCE;

HERPESVIRIDAE;

EID: 84877578888     PISSN: 09692126     EISSN: 18784186     Source Type: Journal    
DOI: 10.1016/j.str.2013.03.008     Document Type: Article

References (49)

1. M. Akkaya, and A.N. Barclay Heterogeneity in the CD200R paired receptor family Immunogenetics 62 2010 15 22
2. M. Akkaya, and A.N. Barclay How do pathogens drive the evolution of paired receptors? Eur. J. Immunol. 43 2013 303 313
3. H. Ashkenazy, E. Erez, E. Martz, T. Pupko, and N. Ben-Tal ConSurf 2010: calculating evolutionary conservation in sequence and structure of proteins and nucleic acids Nucleic Acids Res. 38 Web Server issue 2010 W529-33
4. A.N. Barclay Membrane proteins with immunoglobulin-like domains - a master superfamily of interaction molecules Semin. Immunol. 15 2003 215 223
5. A.N. Barclay, and H.A. Ward Purification and chemical characterisation of membrane glycoproteins from rat thymocytes and brain, recognised by monoclonal antibody MRC OX 2 Eur. J. Biochem. 129 1982 447 458
6. A.N. Barclay, and M.H. Brown The SIRP family of receptors and immune regulation Nat. Rev. Immunol. 6 2006 457 464
7. A.N. Barclay, and D. Hatherley The counterbalance theory for evolution and function of paired receptors Immunity 29 2008 675 678
8. A.N. Barclay, G.J. Wright, G. Brooke, and M.H. Brown CD200 and membrane protein interactions in the control of myeloid cells Trends Immunol. 23 2002 285 290
9. E. Blanc, P. Roversi, C. Vonrhein, C. Flensburg, S.M. Lea, and G. Bricogne Refinement of severely incomplete structures with maximum likelihood in BUSTER-TNT Acta Crystallogr. D Biol. Crystallogr. 60 2004 2210 2221
10. G. Bricogne, E. Blanc, M. Brandl, C. Flensburg, P. Keller, W. Paciorek, P. Roversi, A. Sharff, O.S. Smart, C. Vonrhein, and T.O. Womack BUSTER version 2.11.2 2011 Global Phasing Ltd Cambridge, UK
11. M.H. Brown, K. Boles, P.A. van der Merwe, V. Kumar, P.A. Mathew, and A.N. Barclay 2B4, the natural killer and T cell immunoglobulin superfamily surface protein, is a ligand for CD48 J. Exp. Med. 188 1998 2083 2090
12. M.P. Chao, I.L. Weissman, and R. Majeti The CD47-SIRPα pathway in cancer immune evasion and potential therapeutic implications Curr. Opin. Immunol. 24 2012 225 232
13. M.J. Clark, J. Gagnon, A.F. Williams, and A.N. Barclay MRC OX-2 antigen: a lymphoid/neuronal membrane glycoprotein with a structure like a single immunoglobulin light chain EMBO J. 4 1985 113 118
14. K. Cowtan The Buccaneer software for automated model building. 1. Tracing protein chains Acta Crystallogr. D Biol. Crystallogr. 62 2006 1002 1011
15. S.J. Davis, M.J. Puklavec, D.A. Ashford, K. Harlos, E.Y. Jones, D.I. Stuart, and A.F. Williams Expression of soluble recombinant glycoproteins with predefined glycosylation: application to the crystallization of the T-cell glycoprotein CD2 Protein Eng. 6 1993 229 232
16. E. Fortelle, and G. Bricogne Maximum-likelihood heavy-atom parameter refinement for multiple isomorphous replacement and multiwavelength anomalous diffraction methods C.W. Carter, R.M. Sweet, Methods in Enzymology 1997 Academic Press New York 472 494
17. P. Emsley, and K. Cowtan Coot: model-building tools for molecular graphics Acta Crystallogr. D Biol. Crystallogr. 60 2004 2126 2132
18. P.R. Evans Scala Joint CCP4 + ESF-EAMCB Newsletter on Protein Crystallography 33 1997 22 24
19. M. Foster-Cuevas, G.J. Wright, M.J. Puklavec, M.H. Brown, and A.N. Barclay Human herpesvirus 8 K14 protein mimics CD200 in down-regulating macrophage activation through CD200 receptor J. Virol. 78 2004 7667 7676
20. M. Foster-Cuevas, T. Westerholt, M. Ahmed, M.H. Brown, A.N. Barclay, and S. Voigt Cytomegalovirus e127 protein interacts with the inhibitory CD200 receptor J. Virol. 85 2011 6055 6059
21. R.M. Gorczynski, M.S. Cattral, Z. Chen, J. Hu, J. Lei, W.P. Min, G. Yu, and J. Ni An immunoadhesin incorporating the molecule OX-2 is a potent immunosuppressant that prolongs allo- and xenograft survival J. Immunol. 163 1999 1654 1660
22. R.M. Gorczynski, Z. Chen, K. Yu, and J. Hu CD200 immunoadhesin suppresses collagen-induced arthritis in mice Clin. Immunol. 101 2001 328 334
23. R. Gorczynski, Z. Chen, Y. Kai, L. Lee, S. Wong, and P.A. Marsden CD200 is a ligand for all members of the CD200R family of immunoregulatory molecules J. Immunol. 172 2004 7744 7749
24. D. Hatherley, and A.N. Barclay The CD200 and CD200 receptor cell surface proteins interact through their N-terminal immunoglobulin-like domains Eur. J. Immunol. 34 2004 1688 1694
25. D. Hatherley, H.M. Cherwinski, M. Moshref, and A.N. Barclay Recombinant CD200 protein does not bind activating proteins closely related to CD200 receptor J. Immunol. 175 2005 2469 2474
26. D. Hatherley, S.C. Graham, J. Turner, K. Harlos, D.I. Stuart, and A.N. Barclay Paired receptor specificity explained by structures of signal regulatory proteins alone and complexed with CD47 Mol. Cell 31 2008 266 277
27. A. Kretz-Rommel, F. Qin, N. Dakappagari, E.P. Ravey, J. McWhirter, D. Oltean, S. Frederickson, T. Maruyama, M.A. Wild, and M.-J. Nolan CD200 expression on tumor cells suppresses antitumor immunity: new approaches to cancer immunotherapy J. Immunol. 178 2007 5595 5605
28. E. Krissinel, and K. Henrick Inference of macromolecular assemblies from crystalline state J. Mol. Biol. 372 2007 774 797
29. M.A. Larkin, G. Blackshields, N.P. Brown, R. Chenna, P.A. McGettigan, H. McWilliam, F. Valentin, I.M. Wallace, A. Wilm, and R. Lopez Clustal W and Clustal X version 2.0 Bioinformatics 23 2007 2947 2948
30. A. Leslie Recent changes to the MOSFLM package for processing film and image plate data Joint CCP4 + ESF-EAMCB Newsletter on Protein Crystallography 26 1992
31. S. Mallett, S. Fossum, and A.N. Barclay Characterization of the MRC OX40 antigen of activated CD4 positive T lymphocytes - a molecule related to nerve growth factor receptor EMBO J. 9 1990 1063 1068
32. A.J. McCoy, R.W. Grosse-Kunstleve, P.D. Adams, M.D. Winn, L.C. Storoni, and R.J. Read Phaser crystallographic software J. Appl. Cryst. 40 2007 658 674
33. C. Metcalfe, P. Cresswell, L. Ciaccia, B. Thomas, and A.N. Barclay Labile disulfide bonds are common at the leucocyte cell surface Open Biology 1 2011 10.1098/rsob.110010
34. R. Mihrshahi, A.N. Barclay, and M.H. Brown Essential roles for Dok2 and RasGAP in CD200 receptor-mediated regulation of human myeloid cells J. Immunol. 183 2009 4879 4886
35. K. Misstear, S.A. Chanas, S.A.R. Rezaee, R. Colman, L.L. Quinn, H.M. Long, O. Goodyear, J.M. Lord, A.D. Hislop, and D.J. Blackbourn Suppression of antigen-specific T cell responses by the Kaposi's sarcoma-associated herpesvirus viral OX2 protein and its cellular orthologue, CD200 J. Virol. 86 2012 6246 6257
36. J. Moreaux, D. Hose, T. Reme, E. Jourdan, M. Hundemer, E. Legouffe, P. Moine, P. Bourin, M. Moos, and J. Corre CD200 is a new prognostic factor in multiple myeloma Blood 108 2006 4194 4197
37. S. Mukhopadhyay, A. Plüddemann, J.C. Hoe, K.J. Williams, A. Varin, K. Makepeace, M.-L. Aknin, D.M.E. Bowdish, S.T. Smale, A.N. Barclay, and S. Gordon Immune inhibitory ligand CD200 induction by TLRs and NLRs limits macrophage activation to protect the host from meningococcal septicemia Cell Host Microbe 8 2010 236 247
38. C. Nathan, and W.A. Muller Putting the brakes on innate immunity: a regulatory role for CD200? Nat. Immunol. 2 2001 17 19
39. M.D. Rosenblum, E.B. Olasz, K.B. Yancey, J.E. Woodliff, Z. Lazarova, K.A. Gerber, and R.L. Truitt Expression of CD200 on epithelial cells of the murine hair follicle: a role in tissue-specific immune tolerance? J. Invest. Dermatol. 123 2004 880 887
40. R.J. Snelgrove, J. Goulding, A.M. Didierlaurent, D. Lyonga, S. Vekaria, L. Edwards, E. Gwyer, J.D. Sedgwick, A.N. Barclay, and T. Hussell A critical function for CD200 in lung immune homeostasis and the severity of influenza infection Nat. Immunol. 9 2008 1074 1083
41. P. Stanley Chinese hamster ovary cell mutants with multiple glycosylation defects for production of glycoproteins with minimal carbohydrate heterogeneity Mol. Cell. Biol. 9 1989 377 383
42. A. Tonks, R. Hills, P. White, B. Rosie, K.I. Mills, A.K. Burnett, and R.L. Darley CD200 as a prognostic factor in acute myeloid leukaemia Leukemia 21 2007 566 568
43. D. Voehringer, D.B. Rosen, L.L. Lanier, and R.M. Locksley CD200 receptor family members represent novel DAP12-associated activating receptors on basophils and mast cells J. Biol. Chem. 279 2004 54117 54123
44. G. Winter xia2: an expert system for macromolecular crystallography data reduction J. Appl. Cryst. 43 2010 186 190
45. G.J. Wright, M.J. Puklavec, A.C. Willis, R.M. Hoek, J.D. Sedgwick, M.H. Brown, and A.N. Barclay Lymphoid/neuronal cell surface OX2 glycoprotein recognizes a novel receptor on macrophages implicated in the control of their function Immunity 13 2000 233 242
46. G.J. Wright, M. Jones, M.J. Puklavec, M.H. Brown, and A.N. Barclay The unusual distribution of the neuronal/lymphoid cell surface CD200 (OX2) glycoprotein is conserved in humans Immunology 102 2001 173 179
47. G.J. Wright, H. Cherwinski, M. Foster-Cuevas, G. Brooke, M.J. Puklavec, M. Bigler, Y. Song, M. Jenmalm, D. Gorman, and T. McClanahan Characterization of the CD200 receptor family in mice and humans and their interactions with CD200 J. Immunol. 171 2003 3034 3046
48. S. Zhang, H. Cherwinski, J.D. Sedgwick, and J.H. Phillips Molecular mechanisms of CD200 inhibition of mast cell activation J. Immunol. 173 2004 6786 6793
49. L. Zhang, M. Stanford, J. Liu, C. Barrett, L. Jiang, A.N. Barclay, and G. McFadden Inhibition of macrophage activation by the myxoma virus M141 protein (vCD200) J. Virol. 83 2009 9602 9607